Randomized clinical trial to evaluate a flexibly-dosed-3-medication combination for up to 6 months in smokers with medical illness
Subjects randomly received either nicotine patch alone for a 10-week, tapering course (n=64) or the combination of nicotine patch, nicotine oral inhaler, and bupropion for an ad-lib duration (n=63).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
127
Patch - 21 mg - taper as able Inhaler - as needed Bupropion SR 150 mg daily
21 mg daily for 6 weeks followed by 14 mg for 2 weeks and then 7 mg for 2 weeks
Umdnj-Rwjms
New Brunswick, New Jersey, United States
Tobacco use abstinence
Time frame: 26 week
Time to first relapse
Time frame: varies
Duration of medication use
Time frame: 26 weeks
Adverse clinical events
Time frame: 26 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.